Wegovy is an injectable (sub-cutaneous) prescription weight loss medicine that is indicated for people with obesity. It should be used with a weight loss plan and physical activity. (Photo by: Michael ...

Following the White House’s recent announcement of price reductions and expanded coverage for GLP-1 medications like Wegovy and Zepbound, many patients searching for obesity treatments are about to ...

SAN ANTONIO — The upcoming Obesity Week meeting will feature new clinical trial data for glucagon-like peptide 1 receptor agonist (GLP-1 RA) drugs, along with deep dives into clinical, social, and ...

Obesity is an epidemic in the America. Four in 10 U.S. adults fit the medical definition of having obesity, which puts them at risk for serious health problems, including diabetes, heart disease and ...

Forbes contributors publish independent expert analyses and insights. Joshua Cohen is a Boston-based writer who covers health policy. Medications known as glucagon-like peptide-1 agonists, or GLP-1s, ...

Many health issues including cardiovascular disease, tobacco use, and HIV require both prevention and treatment approaches to support optimal health. Former Centers for Disease Control and Prevention ...

Scientists may have found a new way to spot early signs of obesity, which could lead to novel prevention strategies. A study published in the journal Cell Reports has discovered that people living ...

Obesity prevention strategies often focus on diet, but eating behaviors also play a key role. In a recent study, researchers from Japan investigated factors influencing meal duration, including sex ...